ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.360
+0.150 (12.40%)
At close: May 12, 2025, 4:00 PM
1.390
+0.030 (2.21%)
After-hours: May 12, 2025, 7:59 PM EDT
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $21.82 million as of May 12, 2025. Its market cap has increased by 39.86% in one year.
Market Cap
21.82M
Enterprise Value
25.28M
1-Year Change
39.86%
Ranking
Category
Stock Price
$1.36
Market Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $21.82M, a decrease of -72.56%. That is a compound annual growth rate of -29.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 20.30M | 163.64% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |